• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与年龄相关的线粒体功能障碍是 COVID-19 疾病的关键因素。

Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.

机构信息

Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide-CSIC, CIBERER, Instituto de Salud Carlos III, 41013 Sevilla, Spain.

Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide-CSIC, CIBERER, Instituto de Salud Carlos III, 41013 Sevilla, Spain.

出版信息

Exp Gerontol. 2020 Dec;142:111147. doi: 10.1016/j.exger.2020.111147. Epub 2020 Nov 7.

DOI:10.1016/j.exger.2020.111147
PMID:33171276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7648491/
Abstract

SARS-CoV-2 causes a severe pneumonia (COVID-19) that affects essentially elderly people. In COVID-19, macrophage infiltration into the lung causes a rapid and intense cytokine storm leading finally to a multi-organ failure and death. Comorbidities such as metabolic syndrome, obesity, type 2 diabetes, lung and cardiovascular diseases, all of them age-associated diseases, increase the severity and lethality of COVID-19. Mitochondrial dysfunction is one of the hallmarks of aging and COVID-19 risk factors. Dysfunctional mitochondria is associated with defective immunological response to viral infections and chronic inflammation. This review discuss how mitochondrial dysfunction is associated with defective immune response in aging and different age-related diseases, and with many of the comorbidities associated with poor prognosis in the progression of COVID-19. We suggest here that chronic inflammation caused by mitochondrial dysfunction is responsible of the explosive release of inflammatory cytokines causing severe pneumonia, multi-organ failure and finally death in COVID-19 patients. Preventive treatments based on therapies improving mitochondrial turnover, dynamics and activity would be essential to protect against COVID-19 severity.

摘要

SARS-CoV-2 导致一种严重的肺炎(COVID-19),主要影响老年人。在 COVID-19 中,巨噬细胞浸润肺部导致快速且强烈的细胞因子风暴,最终导致多器官衰竭和死亡。代谢综合征、肥胖、2 型糖尿病、肺部和心血管疾病等合并症都是与年龄相关的疾病,增加了 COVID-19 的严重程度和致死率。线粒体功能障碍是衰老和 COVID-19 危险因素的特征之一。功能失调的线粒体与病毒感染和慢性炎症的免疫反应缺陷有关。本综述讨论了线粒体功能障碍如何与衰老和不同与年龄相关的疾病中的免疫反应缺陷以及与 COVID-19 进展中预后不良相关的许多合并症有关。我们在这里提出,线粒体功能障碍引起的慢性炎症是导致 COVID-19 患者发生严重肺炎、多器官衰竭和最终死亡的炎症细胞因子爆发的原因。基于改善线粒体周转率、动力学和活性的治疗的预防治疗对于预防 COVID-19 的严重程度至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/7648491/58e9d7bfe789/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/7648491/0c6c1c7ca538/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/7648491/31f7adfa539f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/7648491/58e9d7bfe789/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/7648491/0c6c1c7ca538/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/7648491/31f7adfa539f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/7648491/58e9d7bfe789/gr3_lrg.jpg

相似文献

1
Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.与年龄相关的线粒体功能障碍是 COVID-19 疾病的关键因素。
Exp Gerontol. 2020 Dec;142:111147. doi: 10.1016/j.exger.2020.111147. Epub 2020 Nov 7.
2
Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.新型冠状病毒免疫病理学中低度炎症的意义。
MEDICC Rev. 2021 Apr;23(2):42. doi: 10.37757/MR2021.V23.N2.4. Epub 2021 Apr 30.
3
Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?炎症衰老和凝血衰老是否在导致 COVID-19 老年人中严重炎症状态和致命性凝血障碍同时发生的条件中起作用?
Exp Gerontol. 2021 Aug;151:111423. doi: 10.1016/j.exger.2021.111423. Epub 2021 May 26.
4
Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the Caused by SARS-CoV-2?己酮可可碱和别嘌呤醇:预防 SARS-CoV-2 引起的疾病的潜在药物?
Curr Pharm Des. 2020;26(35):4515-4521. doi: 10.2174/1381612826666200811180232.
5
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.免疫反应随衰老而重塑:免疫衰老及其对 COVID-19 免疫反应的潜在影响。
Front Immunol. 2020 Aug 7;11:1748. doi: 10.3389/fimmu.2020.01748. eCollection 2020.
6
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺,增加白细胞介素-1 水平,导致 COVID-19 中的细胞因子风暴和炎症反应。
J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.
7
Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.脓毒症相关细胞因子风暴中的 Toll 样受体及其内源性负性调节因子作为未来的免疫调节靶点。
Int Immunopharmacol. 2020 Dec;89(Pt B):107087. doi: 10.1016/j.intimp.2020.107087. Epub 2020 Oct 12.
8
Adaptive Metabolic and Inflammatory Responses Identified Using Accelerated Aging Metrics Are Linked to Adverse Outcomes in Severe SARS-CoV-2 Infection.使用加速衰老指标识别出的适应性代谢和炎症反应与严重SARS-CoV-2感染的不良结局相关。
J Gerontol A Biol Sci Med Sci. 2021 Jul 13;76(8):e117-e126. doi: 10.1093/gerona/glab078.
9
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).白细胞介素-1(IL-1)在 COVID-19 中诱导血栓烷 A2(TxA2)的产生,导致炎症和微血栓形成:白细胞介素-1 受体拮抗剂(IL-1Ra)的抑制作用。
J Biol Regul Homeost Agents. 2020;34(5):1623-1627. doi: 10.23812/20-34-4EDIT-65.
10
Immunological basis of virus-host interaction in COVID-19.COVID-19 中病毒-宿主相互作用的免疫学基础。
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26(Suppl 26):75-78. doi: 10.1111/pai.13363.

引用本文的文献

1
The peptidoglycan of can persist in discrete tissues and cause systemic responses consistent with chronic illness.[此处原文中“of”后缺少具体内容]的肽聚糖可在离散组织中持续存在,并引发与慢性病一致的全身反应。
Sci Transl Med. 2025 Apr 23;17(795):eadr2955. doi: 10.1126/scitranslmed.adr2955.
2
Research advances in polyphenols from Chinese herbal medicine for the prevention and treatment of chronic obstructive pulmonary disease: a review.中药多酚类物质防治慢性阻塞性肺疾病的研究进展:综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 4. doi: 10.1007/s00210-025-03945-y.
3
SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms.

本文引用的文献

1
The metabolic basis of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的代谢基础
Endocrinol Diabetes Metab. 2020 Feb 24;3(4):e00112. doi: 10.1002/edm2.112. eCollection 2020 Oct.
2
Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses.引发对抗:微调线粒体针对RNA病毒的先天性免疫防御
Front Microbiol. 2020 Aug 31;11:1990. doi: 10.3389/fmicb.2020.01990. eCollection 2020.
3
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
SARS-CoV-2 感染与α-突触核蛋白病:潜在关联及潜在机制。
Int J Mol Sci. 2024 Nov 10;25(22):12079. doi: 10.3390/ijms252212079.
4
Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release.COVID-19 患者血清中的 mtDNA 升高与 SARS-CoV-2 包膜蛋白靶向线粒体 VDAC1 有关,后者诱导细胞凋亡和 mtDNA 释放。
Apoptosis. 2024 Dec;29(11-12):2025-2046. doi: 10.1007/s10495-024-02025-5. Epub 2024 Oct 7.
5
Mitochondria in COVID-19: from cellular and molecular perspective.新型冠状病毒肺炎中的线粒体:从细胞和分子角度看
Front Physiol. 2024 Jun 21;15:1406635. doi: 10.3389/fphys.2024.1406635. eCollection 2024.
6
COVID-19 and silent hypoxemia in a minimal closed-loop model of the respiratory rhythm generator.COVID-19 和呼吸节律发生器最小闭环模型中的隐匿性低氧血症。
Biol Cybern. 2024 Aug;118(3-4):145-163. doi: 10.1007/s00422-024-00989-w. Epub 2024 Jun 17.
7
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.精准营养以重置长期新冠病毒感染中病毒诱导的人类代谢重编程和失调(HMRD)。
NPJ Sci Food. 2024 Mar 30;8(1):19. doi: 10.1038/s41538-024-00261-2.
8
Association of Inflammatory Mediators with Mitochondrial DNA Variants in Geriatric COVID-19 Patients.老年 COVID-19 患者中炎症介质与线粒体 DNA 变异的相关性。
Aging Dis. 2024 Feb 9;15(6):2665-2681. doi: 10.14336/AD.2023.1123.
9
Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage.COVID-19 对线粒体和多器官损伤影响的转录组学和机器学习分析。
PLoS One. 2024 Jan 31;19(1):e0297664. doi: 10.1371/journal.pone.0297664. eCollection 2024.
10
SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)开放阅读框8作为细胞因子诱导的调节因子:证据及分子机制探索
Viruses. 2024 Jan 22;16(1):161. doi: 10.3390/v16010161.
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
4
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
5
Mitochondrial destiny in type 2 diabetes: the effects of oxidative stress on the dynamics and biogenesis of mitochondria.2型糖尿病中线粒体的命运:氧化应激对线粒体动力学和生物发生的影响
PeerJ. 2020 Aug 25;8:e9741. doi: 10.7717/peerj.9741. eCollection 2020.
6
Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial.干扰素 β-1b 治疗重症 COVID-19:一项随机临床试验。
Int Immunopharmacol. 2020 Nov;88:106903. doi: 10.1016/j.intimp.2020.106903. Epub 2020 Aug 24.
7
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study.COVID-19 相关性急性呼吸窘迫综合征的病理生理学:一项多中心前瞻性观察研究。
Lancet Respir Med. 2020 Dec;8(12):1201-1208. doi: 10.1016/S2213-2600(20)30370-2. Epub 2020 Aug 27.
8
Obesity: A critical risk factor in the COVID-19 pandemic.肥胖:新冠疫情中的一个关键风险因素。
Clin Obes. 2020 Dec;10(6):e12403. doi: 10.1111/cob.12403. Epub 2020 Aug 28.
9
Inflammation brakes mitochondrial metabolism in obesity.炎症抑制肥胖中的线粒体代谢。
Nat Immunol. 2020 Oct;21(10):1143-1145. doi: 10.1038/s41590-020-0780-8.
10
The Role of HIF in Immunity and Inflammation.缺氧诱导因子在免疫与炎症中的作用。
Cell Metab. 2020 Oct 6;32(4):524-536. doi: 10.1016/j.cmet.2020.08.002. Epub 2020 Aug 26.